Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Marqeta, Inc. - Class A Common Stock (NQ:MQ)

5.710 -0.270 (-4.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Marqeta, Inc. - Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Majority of Households Have Changed Their Budgets Amid Rising Economic Uncertainty, According to New Marqeta Global Consumer Pulse Report
From Marqeta, Inc.
Via Business Wire
What 11 Analyst Ratings Have To Say About Marqeta
Via Benzinga
Is Marqeta Stock a Buy Right Now?
Shares tanked after earnings, and the market remains focused on immediate-term risks. 
Via The Motley Fool
Marqeta Stock Is Trading Down Today: What's Going On?
Marqeta Inc (NASDAQ: MQ) shares are trading lower Wednesday after the company reported fourth-quarter results. 
Via Benzinga
WorkWhile and Marqeta Announce Partnership on New Card Solution to Offer Accelerated Wage Access for WorkWhile Workers
From Marqeta
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 27, 2023
Via Benzinga
Marqeta Analyst Turns Bullish, Sees 'Clear Path To Profitability'
Marqeta Inc (NASDAQ: MQ) stock has experienced a selloff, hitting 52-week lows on Thursday. 
Via Benzinga
Marqeta (MQ) Q4 2022 Earnings Call Transcript
MQ earnings call for the period ending December 31, 2022. 
Via The Motley Fool
The Latest Analyst Ratings for Marqeta
Via Benzinga
Better Buy: Marqeta or Bill.com?
These two fintechs have had strong revenue growth, but neither is profitable -- yet. 
Via The Motley Fool
5 Best Growth Stocks to Buy Now Under $10 (AI Stocks to Buy)
These 5 growth stocks leverage artificial intelligence and are beaten down from their highs. Are these stock picks diamonds in the rough that can supercharge your growth stock portfolio? 
Via The Motley Fool
10 Information Technology Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Marqeta Gets 33% Price Target Cut By Analysts, Cite Block Renewal Uncertainty
Keybanc analyst Josh Beck maintained Marqeta Inc (NASDAQ: MQ) with an Overweight and lowered 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, March 1
Here are the most active equity options for midday. 
Via Talk Markets
Here's Why Marqeta Can Be a Long-Term Winner
This fintech has a growing business and enormous opportunities. 
Via The Motley Fool
Better Buy: Marqeta vs. PayPal
Is this a contest of growth vs. value? 
Via The Motley Fool
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Dow Looking To Rebound After Rocky February
The Dow Jones Industrial Average is up 81 points this afternoon, while the S&P 500 Index and Nasdaq Composite are lower, with stocks kicking off a new month after a February decline. 
Via Talk Markets
12 Information Technology Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
What's Going On With Marqeta Stock After Hours?
Marqeta Inc (NASDAQ: MQ) shares are trading lower in Tuesday's after-hours session after the company reported fourth-quarter results and issued guidance  
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Marqeta Reports Fourth Quarter and Full Year 2022 Financial Results
From Marqeta, Inc.
Via Business Wire
Marqeta Appoints Crystal Sumner as Chief Legal Officer
From Marqeta
Via Business Wire
What Marqeta's First-Ever Acquisition Means for Investors
What are shareholders getting for their $223 million? 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.